NCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
10 trialsNCT06076538 2025-12-29
PET/MR for Characterization of Renal Masses (RMs)
University of Texas Southwestern Medical Center
Recruiting
NCT04369560 2025-12-17
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
University of Pittsburgh
Phase EARLY_PHASE1 Recruiting
NCT07249281 2025-11-25
MR Microstructural Imaging for Prostate Cancer Diagnosis
First Affiliated Hospital of Zhejiang University
Recruiting
NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT07048613 2025-07-02
Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups
Superior University
Active not recruiting
NCT06116253 2025-06-24
Advanced Diffusion Imaging in Renal Cancer Patients
NYU Langone Health
Phase NA Recruiting
NCT04685928 2025-05-06
SMART
Chinese University of Hong Kong
Phase NA Completed
NCT05384002 2025-04-04
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
Fondazione del Piemonte per l'Oncologia
Completed